All Stories

  1. The effects of exogenous desmopressin on a model of heat stress nephropathy in mice

    Article • AJP Renal Physiology, December 2016, American Physiological Society

    LAURA G SANCHEZ-LOZADA

  2. Role of Fructose and Fructokinase in Acute Dehydration Induced Vasopressin Gene Expression and Secretion in Mice

    Article • Journal of Neurophysiology, November 2016, American Physiological Society

    LAURA G SANCHEZ-LOZADA

  3. Curcumin prevents mitochondrial dynamics disturbances in early 5/6 nephrectomy: Relation to oxidative stress and mitochondrial bioenergetics

    Article • BioFactors, November 2016, Wiley

    LAURA G SANCHEZ-LOZADA

  4. Aging-associated renal disease in mice is fructokinase dependent

    Article • AJP Renal Physiology, July 2016, American Physiological Society

    LAURA G SANCHEZ-LOZADA

  5. The nephroprotection exerted by curcumin in maleate-induced renal damage is associated with decreased mitochondrial fission and autophagy

    Article • BioFactors, July 2016, Wiley

    LAURA G SANCHEZ-LOZADA

  6. Climate change and kidney disease

    Article • Clinical Journal of the American Society of Nephrology, May 2016, American Society of Nephrology

    Ricardo Correa-Rotter, Prof Vivekanand Jha, Ramon García-Trabanino, Prof Peter Stenvinkel, LAURA G SANCHEZ-LOZADA

  7. Mycophenolate mofetil and curcumin provide comparable therapeutic benefit in experimental chronic kidney disease: role of Nrf2-Keap1 and renal dopamine pathways

    Article • Free Radical Research, May 2016, Taylor & Francis

    LAURA G SANCHEZ-LOZADA

  8. Rehydration with soft drink-like beverages exacerbates dehydration and worsens dehydration-associated renal injury

    Article • AJP Regulatory Integrative and Comparative Physiology, April 2016, American Physiological Society

    LAURA G SANCHEZ-LOZADA

  9. Heat Stress Nephropathy From Exercise-Induced Uric Acid Crystalluria: A Perspective on Mesoamerican Nephropathy

    Article • American Journal of Kidney Diseases, January 2016, Elsevier

    Ramon García-Trabanino, LAURA G SANCHEZ-LOZADA

  10. Anti-Inflammatory Therapy Modulates Nrf2-Keap1 in Kidney from Rats with Diabetes

    Article • Oxidative Medicine and Cellular Longevity, January 2016, Hindawi Publishing Corporation

    LAURA G SANCHEZ-LOZADA

  11. Hyponatremia with Persistent Elevated Urinary Fractional Uric Acid Excretion: Evidence for Proximal Tubular Injury?

    Article • Kidney and Blood Pressure Research, January 2016, Karger Publishers

    LAURA G SANCHEZ-LOZADA

  12. New Pathogenic Concepts and Therapeutic Approaches to Oxidative Stress in Chronic Kidney Disease

    Article • Oxidative Medicine and Cellular Longevity, January 2016, Hindawi Publishing Corporation

    LAURA G SANCHEZ-LOZADA, Dr. Alexandra Scholze

  13. Effects of Allicin on Hypertension and Cardiac Function in Chronic Kidney Disease

    Article • Oxidative Medicine and Cellular Longevity, January 2016, Hindawi Publishing Corporation

    LAURA G SANCHEZ-LOZADA

  14. Mechanisms by Which Dehydration May Lead to Chronic Kidney Disease

    Article • Annals of Nutrition and Metabolism, June 2015, Karger Publishers

    LAURA G SANCHEZ-LOZADA

  15. Diabetes and Kidney Disease in American Indians: Potential Role of Sugar-Sweetened Beverages

    Article • Mayo Clinic Proceedings, June 2015, Elsevier

    LAURA G SANCHEZ-LOZADA

  16. Opposing Activity Changes in AMP Deaminase and AMP-Activated Protein Kinase in the Hibernating Ground Squirrel

    Article • PLoS ONE, April 2015, PLOS

    LAURA G SANCHEZ-LOZADA

  17. Hispanic Americans living in the United States and their risk for obesity, diabetes and kidney disease: Genetic and environmental considerations

    Article • Postgraduate Medicine, March 2015, Taylor & Francis

    LAURA G SANCHEZ-LOZADA

  18. Renal Oxidative Stress Induced by Long-Term Hyperuricemia Alters Mitochondrial Function and Maintains Systemic Hypertension

    Article • Oxidative Medicine and Cellular Longevity, January 2015, Hindawi Publishing Corporation

    LAURA G SANCHEZ-LOZADA

  19. Renal tight junction proteins are decreased in cisplatin-induced nephrotoxicity in rats

    Article • Toxicology Mechanisms and Methods, August 2014, Taylor & Francis

    LAURA G SANCHEZ-LOZADA

  20. Fructokinase activity mediates dehydration-induced renal injury

    Article • Kidney International, August 2014, Elsevier

    LAURA G SANCHEZ-LOZADA

  21. Hyperosmolarity drives hypertension and CKD—water and salt revisited

    Article • Nature Reviews Nephrology, May 2014, Nature

    LAURA G SANCHEZ-LOZADA

  22. Urinary Excretion of Neutrophil Gelatinase-Associated Lipocalin in Diabetic Rats

    Article • Oxidative Medicine and Cellular Longevity, January 2014, Hindawi Publishing Corporation

    LAURA G SANCHEZ-LOZADA

  23. Corrigendum: Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome

    Article • Nature Communications, December 2013, Nature

    LAURA G SANCHEZ-LOZADA

  24. Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome

    Article • Nature Communications, September 2013, Nature

    LAURA G SANCHEZ-LOZADA

  25. Chronic kidney disease: Mesoamerican nephropathy—new clues to the cause

    Article • Nature Reviews Nephrology, September 2013, Nature

    LAURA G SANCHEZ-LOZADA

  26. Uric Acid and the Origins of Hypertension

    Article • The Journal of Pediatrics, May 2013, Elsevier

    LAURA G SANCHEZ-LOZADA

  27. Redefining metabolic syndrome as a fat storage condition based on studies of comparative physiology

    Article • Obesity, April 2013, Wiley

    LAURA G SANCHEZ-LOZADA

  28. Uric acid and chronic kidney disease: which is chasing which?

    Article • Nephrology Dialysis Transplantation, March 2013, Oxford University Press (OUP)

    LAURA G SANCHEZ-LOZADA

  29. What Are the Key Arguments Against Uric Acid as a True Risk Factor for Hypertension?

    Article • Hypertension, March 2013, Wolters Kluwer Health

    LAURA G SANCHEZ-LOZADA

  30. Counteracting Roles of AMP Deaminase and AMP Kinase in the Development of Fatty Liver

    Article • PLoS ONE, November 2012, PLOS

    LAURA G SANCHEZ-LOZADA

  31. Uric Acid Stimulates Fructokinase and Accelerates Fructose Metabolism in the Development of Fatty Liver

    Article • PLoS ONE, October 2012, PLOS

    LAURA G SANCHEZ-LOZADA

  32. Effects of Excessive Fructose Intake on Health

    Article • Annals of Internal Medicine, June 2012, American College of Physicians

    LAURA G SANCHEZ-LOZADA

  33. Sildenafil Treatment Prevents Glomerular Hypertension and Hyperfiltration in Rats with Renal Ablation

    Article • Kidney and Blood Pressure Research, January 2012, Karger Publishers

    LAURA G SANCHEZ-LOZADA

  34. Uric Acid-Induced Endothelial Dysfunction Is Associated with Mitochondrial Alterations and Decreased Intracellular ATP Concentrations

    Article • Nephron Experimental Nephrology, January 2012, Karger Publishers

    LAURA G SANCHEZ-LOZADA

  35. The effect of two energy-restricted diets, a low-fructose diet versus a moderate natural fructose diet, on weight loss and metabolic syndrome parameters: a randomized controlled trial

    Article • Metabolism, November 2011, Elsevier

    LAURA G SANCHEZ-LOZADA

  36. The Rediscovery of Uric Acid in Cardiorenal Disease: Introduction

    Article • Seminars in Nephrology, September 2011, Elsevier

    LAURA G SANCHEZ-LOZADA

  37. Uric Acid and Fructose: Potential Biological Mechanisms

    Article • Seminars in Nephrology, September 2011, Elsevier

    LAURA G SANCHEZ-LOZADA

  38. Uric Acid: A Clinically Useful Marker to Distinguish Preeclampsia From Gestational Hypertension

    Article • Hypertension, August 2011, Wolters Kluwer Health

    LAURA G SANCHEZ-LOZADA

  39. Uric acid and Metabolic Syndrome: What is the Relationship?

    Article • Current Rheumatology Reviews, May 2011, Bentham Science Publishers

    LAURA G SANCHEZ-LOZADA

  40. The Effect of Fructose on Renal Biology and Disease

    Article • Journal of the American Society of Nephrology, November 2010, American Society of Nephrology

    LAURA G SANCHEZ-LOZADA

  41. Dietary Fructose and Hypertension

    Article • Current Hypertension Reports, October 2010, Springer Science + Business Media

    LAURA G SANCHEZ-LOZADA

  42. Response to Dr White

    Article • International Journal of Obesity, September 2010, Nature

    LAURA G SANCHEZ-LOZADA

  43. Oxidative stress with an activation of the renin–angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction

    Article • Journal of Hypertension, March 2010, Wolters Kluwer Health

    LAURA G SANCHEZ-LOZADA

  44. Hypertension: New treatment target for systolic blood pressure?

    Article • Nature Reviews Nephrology, December 2009, Nature

    LAURA G SANCHEZ-LOZADA

  45. Uric Acid: More to Learn, More Experiments to Do

    Article • American Journal of Hypertension, September 2009, Oxford University Press (OUP)

    LAURA G SANCHEZ-LOZADA

  46. Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver

    Article • European Journal of Nutrition, July 2009, Springer Science + Business Media

    Professor Hui Yao Lan, LAURA G SANCHEZ-LOZADA

  47. Hypothesis: Could Excessive Fructose Intake and Uric Acid Cause Type 2 Diabetes?

    Article • Endocrine Reviews, February 2009, Endocrine Society

    LAURA G SANCHEZ-LOZADA

  48. Treatment with pyrrolidine dithiocarbamate improves proteinuria, oxidative stress, and glomerular hypertension in overload proteinuria

    Article • AJP Renal Physiology, August 2008, American Physiological Society

    LAURA G SANCHEZ-LOZADA

  49. Pathogenesis of essential hypertension: historical paradigms and modern insights

    Article • Journal of Hypertension, March 2008, Wolters Kluwer Health

    LAURA G SANCHEZ-LOZADA

  50. Pathophysiology of Salt-Sensitive Hypertension: A New Scope of an Old Problem

    Article • Blood Purification, January 2008, Karger Publishers

    LAURA G SANCHEZ-LOZADA

  51. Hormonal and cytokine effects of uric acid

    Article • Current Opinion in Nephrology & Hypertension, January 2006, Wolters Kluwer Health

    LAURA G SANCHEZ-LOZADA

  52. Uric Acid – A Uremic Toxin?

    Article • Blood Purification, December 2005, Karger Publishers

    LAURA G SANCHEZ-LOZADA

  53. Hemodynamics of hyperuricemia

    Article • Seminars in Nephrology, January 2005, Elsevier

    LAURA G SANCHEZ-LOZADA

  54. Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats

    Article • Kidney International, January 2005, Elsevier

    LAURA G SANCHEZ-LOZADA

  55. Reply from the Authors

    Article • Kidney International, May 2004, Elsevier

    LAURA G SANCHEZ-LOZADA

  56. Glomerular hemodynamic changes associated with arteriolar lesions and tubulointerstitial inflammation

    Article • Kidney International, October 2003, Elsevier

    LAURA G SANCHEZ-LOZADA

  57. Mycophenolate mofetil prevents arteriolopathy and renal injury in subtotal ablation despite persistent hypertension

    Article • Kidney International, March 2003, Elsevier

    LAURA G SANCHEZ-LOZADA

  58. Hyperuricemia Causes Glomerular Hypertrophy in the Rat

    Article • American Journal of Nephrology, October 2002, Karger Publishers

    LAURA G SANCHEZ-LOZADA

  59. Mild hyperuricemia induces glomerular hypertension in normal rats

    Article • AJP Renal Physiology, June 2002, American Physiological Society

    LAURA G SANCHEZ-LOZADA

  60. Nifedipine Prevents Changes in Nitric Oxide Synthase mRNA Levels Induced by Cyclosporine

    Article • Hypertension, October 2000, Wolters Kluwer Health

    LAURA G SANCHEZ-LOZADA